Close Menu
Chicago Times Herald
    What's Hot

    U.S. Trade Balances Improve With Partners

    April 9, 2026

    Artemis II Sparks Everyday Tech Innovations

    April 6, 2026

    Lucas Oil Stadium Sets Attendance Records

    April 2, 2026
    Facebook X (Twitter) Instagram
    Chicago Times Herald
    • News
    • Media
    • Health
    • Sports
    • Education
    • Entertainment
    • Opinion
    • Real Estate
    • More
      • Business & Economy
      • Culture & Society
      • Technology & Innovation
      • Environment & Sustainability
      • Travel & Tourism
    Chicago Times Herald
    • Home
    • Entertainment
    • News
    • Sports
    Home»Technology & Innovation

    Scientists Unveil First Accurate Blood Test for Chronic Fatigue Syndrome

    Andrew RogersBy Andrew RogersOctober 9, 2025 Technology & Innovation No Comments2 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Scientists have developed what they say is the first accurate blood test to diagnose myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS).

    The condition, which causes severe and long-lasting exhaustion not relieved by rest, has no definitive diagnostic test. Patients are usually diagnosed through symptoms, a process that can take years and lead to frequent misdiagnosis.

    Researchers from the University of East Anglia (UEA) and Oxford Biodynamics (OBD) say their new blood test could change that. By studying how DNA folds in the blood, they identified a distinct molecular pattern seen only in people with ME/CFS.

    The study, published in The Journal of Translational Medicine, examined samples from 47 patients with severe ME/CFS and 61 healthy adults. The test correctly identified the condition with 92% sensitivity and 98% specificity.

    “This is a significant step forward,” said Prof Dmitry Pshezhetskiy from UEA’s Norwich Medical School. “For the first time, we have a simple, reliable blood test that could transform diagnosis and management for ME/CFS patients.”

    Alexandre Akoulitchev, chief scientific officer at OBD, said the test uses “epigenetic markers” that change throughout a person’s life, rather than fixed genetic traits. “That’s why this approach achieved such accuracy,” he explained.

    However, other experts have urged caution. Dr Charles Shepherd from the ME Association said that while the findings are promising, more research is needed to confirm whether the same DNA pattern appears across all stages and severities of the illness.

    He also stressed the need to rule out similar abnormalities in other chronic conditions with overlapping symptoms.

    Prof Chris Ponting from the University of Edinburgh called some of the claims “premature,” warning that the test must be validated independently before being used clinically. “Even if confirmed, it will likely be expensive — around £1,000,” he added.

    Despite the uncertainty, researchers hope the discovery will pave the way for faster, more accurate diagnosis — and greater recognition of a condition that has long been misunderstood.

    Andrew Rogers
    • Website
    • Facebook

    Andrew Rogers is a freelance journalist based in Chicago, USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He graduated with a degree in Journalism from the University of Florida. Over the years, he has contributed to leading outlets such as The New York Times, CNN, and Reuters. Recognized for his sharp reporting and thoughtful analysis, Andrew delivers accurate and timely news that keeps readers updated on key national and global developments.

    Keep Reading

    Artemis II Sparks Everyday Tech Innovations

    U.S. Tech Trends Shape 2026 Investments

    Instagram to Notify Parents When Teens Search for Self-Harm or Suicide

    OpenAI Weighed Police Alert Months Before Deadly Canadian School Shooting

    Discord enforces global age verification to restrict adult content

    Sydney Scientists Recreate Cosmic Dust to Probe Life’s Origins

    Add A Comment
    Leave A Reply Cancel Reply

    Latest News

    Lucas Oil Stadium Sets Attendance Records

    April 2, 2026

    Federal Clean Energy Boosts Jobs, Tech Growth

    March 30, 2026

    Analysts Boost U.S. Stock Market Outlook

    March 27, 2026

    State Lawmakers Tackle Housing and Education

    March 16, 2026
    Trending News

    Unlocking the Secrets of Cocoa Fermentation

    Technology & Innovation August 18, 2025

    Prof. David Salt and his team discovered how microbes impact cocoa bean fermentation and chocolate…

    Declining Sperm Counts Tied to Chemicals in Plastics

    August 19, 2025

    Arctic Sea Ice Decline Hits Pause

    August 20, 2025

    Duolingo Apologises for Lesson Criticising Rowling

    August 21, 2025

    Latest Posts

    U.S. Trade Balances Improve With Partners

    April 9, 2026

    Artemis II Sparks Everyday Tech Innovations

    April 6, 2026

    Lucas Oil Stadium Sets Attendance Records

    April 2, 2026

    Categories

    • Business & Economy
    • Culture & Society
    • Health
    • Entertainment
    • Sports
    • Media
    • News
    • Opinion
    • Real Estate
    • Environment & Sustainability
    • Technology & Innovation
    • Travel & Tourism

    IMPORTANT LINKS

    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer
    • Imprint

    © 2025 Chicagotimesherald.com . All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.